covid-19. https://www.who.int/publications/m/item/covid-19-update-for-icd-10
Conditions
Interventions
Intervention 1: Intervention group: Includes 15 patients who will receive the conditioned-medium by nebulization for 8 days in two doses at 8:30 in the morning and 4 in the afternoon. Intervention 2:
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 60 Years
Inclusion criteria
Inclusion criteria: Patients with Covid 19 who have been infected for a week and who have been hospitalized for 48 hours despite receiving medication and oxygen have not improved their condition and their arterial blood oxygen saturation percentage is below 88%.
Exclusion criteria
Exclusion criteria: Patients with arterial blood oxygen saturation above 88%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment of patients suffer from Covid 19 nebulization of conditioned-medium derived from human adipose tissue mesenchymal stem cell. Timepoint: Comparison of the improvement of patients with covid-19 disease before the intervention and after 5 days of therapeutic intervention. Method of measurement: blood laboratory test , CT-Scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of lung damage. Timepoint: Measurement of lung damage before and after therapeutic intervention. Method of measurement: CT-Scan.;CRP, LDH, WBC measurement. Timepoint: Before and after therapeutic intervention. Method of measurement: blood laboratory test.;Fever. Timepoint: Before and after therapeutic intervention. Method of measurement: Thermometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMona Saheli
Kerman University of Medical Sciences
Outcome results
None listed